PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9864179-2	1999	G-CSF exclusively tyrosine-phosphorylated extracellular signal-regulated kinase (ERK).	Tyrosine	18-26	colony stimulating factor 3	Homo sapiens	0-5	
9864179-2	1999	G-CSF exclusively tyrosine-phosphorylated extracellular signal-regulated kinase (ERK).	Tyrosine	18-26	mitogen-activated protein kinase 1	Homo sapiens	42-79	
9864179-2	1999	G-CSF exclusively tyrosine-phosphorylated extracellular signal-regulated kinase (ERK).	Tyrosine	18-26	mitogen-activated protein kinase 1	Homo sapiens	81-84	
9864179-3	1999	GM-CSF tyrosine-phosphorylated ERK strongly and p38 MAPK weakly, whereas TNF tyrosine-phosphorylated p38 MAPK strongly and ERK weakly.	Tyrosine	7-15	colony stimulating factor 2	Homo sapiens	0-6	
9864179-3	1999	GM-CSF tyrosine-phosphorylated ERK strongly and p38 MAPK weakly, whereas TNF tyrosine-phosphorylated p38 MAPK strongly and ERK weakly.	Tyrosine	7-15	mitogen-activated protein kinase 1	Homo sapiens	31-34	
9864179-3	1999	GM-CSF tyrosine-phosphorylated ERK strongly and p38 MAPK weakly, whereas TNF tyrosine-phosphorylated p38 MAPK strongly and ERK weakly.	Tyrosine	77-85	tumor necrosis factor	Homo sapiens	73-76	
9864179-3	1999	GM-CSF tyrosine-phosphorylated ERK strongly and p38 MAPK weakly, whereas TNF tyrosine-phosphorylated p38 MAPK strongly and ERK weakly.	Tyrosine	77-85	mitogen-activated protein kinase 1	Homo sapiens	101-104	
9864179-6	1999	C-Jun amino-terminal kinase (JNK) was not tyrosine-phosphorylated by any cytokine despite the existence of JNK proteins in human neutrophils, whereas it was tyrosine-phosphorylated by TNF in undifferentiated and all-trans retinoic acid-differentiated HL-60 cells.	Tretinoin	222-235	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	0-5	
9864179-6	1999	C-Jun amino-terminal kinase (JNK) was not tyrosine-phosphorylated by any cytokine despite the existence of JNK proteins in human neutrophils, whereas it was tyrosine-phosphorylated by TNF in undifferentiated and all-trans retinoic acid-differentiated HL-60 cells.	Tretinoin	222-235	mitogen-activated protein kinase 8	Homo sapiens	29-32	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	15-22	mitogen-activated protein kinase kinase 7	Homo sapiens	0-3	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	15-22	mitogen-activated protein kinase 1	Homo sapiens	60-63	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	15-22	colony stimulating factor 3	Homo sapiens	94-99	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	15-22	colony stimulating factor 2	Homo sapiens	101-107	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	15-22	tumor necrosis factor	Homo sapiens	112-115	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	Tyrosine	32-40	mitogen-activated protein kinase kinase 7	Homo sapiens	0-3	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	Tyrosine	32-40	mitogen-activated protein kinase 1	Homo sapiens	60-63	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	Tyrosine	32-40	colony stimulating factor 3	Homo sapiens	94-99	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	Tyrosine	32-40	colony stimulating factor 2	Homo sapiens	101-107	
9864179-8	1999	MEK inhibitor (PD98059) reduced tyrosine phosphorylation of ERK, but not p38 MAPK, induced by G-CSF, GM-CSF, or TNF.	Tyrosine	32-40	tumor necrosis factor	Homo sapiens	112-115	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	23-33	colony stimulating factor 2	Homo sapiens	0-6	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	23-33	tumor necrosis factor	Homo sapiens	11-14	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	23-33	mitogen-activated protein kinase 1	Homo sapiens	65-68	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	23-33	mitogen-activated protein kinase 1	Homo sapiens	162-165	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	23-33	colony stimulating factor 2	Homo sapiens	174-208	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	35-37	colony stimulating factor 2	Homo sapiens	0-6	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	35-37	tumor necrosis factor	Homo sapiens	11-14	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	35-37	mitogen-activated protein kinase 1	Homo sapiens	65-68	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	35-37	mitogen-activated protein kinase 1	Homo sapiens	162-165	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	Superoxides	35-37	colony stimulating factor 2	Homo sapiens	174-208	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	SB 203580	85-93	colony stimulating factor 2	Homo sapiens	0-6	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	SB 203580	85-93	tumor necrosis factor	Homo sapiens	11-14	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	SB 203580	85-93	mitogen-activated protein kinase 1	Homo sapiens	65-68	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	SB 203580	85-93	mitogen-activated protein kinase 1	Homo sapiens	162-165	
9864179-9	1999	GM-CSF- or TNF-induced superoxide (O2-) release was inhibited by p38 MAPK inhibitor (SB203580) in a dose-dependent manner, suggesting the possible involvement of p38 MAPK in GM-CSF- or TNF-induced O2- release.	SB 203580	85-93	colony stimulating factor 2	Homo sapiens	174-208